Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;154(1):83-92.
doi: 10.1007/s11060-021-03801-y. Epub 2021 Jun 30.

Identification of magnetic resonance imaging features for the prediction of molecular profiles of newly diagnosed glioblastoma

Affiliations

Identification of magnetic resonance imaging features for the prediction of molecular profiles of newly diagnosed glioblastoma

Sung Soo Ahn et al. J Neurooncol. 2021 Aug.

Abstract

Purpose: We predicted molecular profiles in newly diagnosed glioblastoma patients using magnetic resonance (MR) imaging features and explored the associations between imaging features and major molecular alterations.

Methods: This retrospective study included patients with newly diagnosed glioblastoma and available next-generation sequencing results. From preoperative MR imaging, Visually AcceSAble Rembrandt Images (VASARI) features, volumetric parameters, and apparent diffusion coefficient (ADC) values were obtained. First, univariate random forest was performed to identify gene abnormalities that could be predicted by imaging features with high accuracy and stability. Next, multivariate random forest was trained to predict the selected genes in the discovery cohort and was validated in the external cohort. Univariable logistic regression was performed to further explore the associations between imaging features and genes.

Results: Univariate random forest identified nine genes predicted by imaging features, with high accuracy and stability. The multivariate random forest model showed excellent performance in predicting IDH and PTPN11 mutations in the discovery cohort, which were validated in the external validation cohorts (areas under the receiver operator characteristic curve [AUCs] of 0.855 for IDH and 0.88 for PTPN11). ATRX loss and EGFR mutation were predicted with AUCs of 0.753 and 0.739, respectively, whereas PTEN could not be reliably predicted. Based on univariable logistic regression analyses, IDH, ATRX, and TP53 were clustered according to their shared imaging features, whereas EGFR and CDKN2A/B were clustered in the opposite direction.

Conclusions: MR imaging features are related to specific molecular alterations and can be used to predict molecular profiles in patients with newly diagnosed glioblastoma.

Keywords: Glioblastoma; Magnetic resonance imaging; Molecular alterations; Molecular profiles.

PubMed Disclaimer

References

    1. Cancer Genome Atlas Research N (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061–1068. https://doi.org/10.1038/nature07385 - DOI
    1. Bonavia R, Inda MM, Cavenee WK, Furnari FB (2011) Heterogeneity maintenance in glioblastoma: a social network. Cancer Res 71:4055–4060. https://doi.org/10.1158/0008-5472.CAN-11-0153 - DOI - PubMed - PMC
    1. Henson JW, Gaviani P, Gonzalez RG (2005) MRI in treatment of adult gliomas. Lancet Oncol 6:167–175. https://doi.org/10.1016/S1470-2045(05)01767-5 - DOI - PubMed
    1. Gevaert O, Mitchell LA, Achrol AS, Xu J, Echegaray S, Steinberg GK, Cheshier SH, Napel S, Zaharchuk G, Plevritis SK (2014) Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology 273:168–174. https://doi.org/10.1148/radiol.14131731 - DOI - PubMed
    1. Wangaryattawanich P, Hatami M, Wang J, Thomas G, Flanders A, Kirby J, Wintermark M, Huang ES, Bakhtiari AS, Luedi MM, Hashmi SS, Rubin DL, Chen JY, Hwang SN, Freymann J, Holder CA, Zinn PO, Colen RR (2015) Multicenter imaging outcomes study of the cancer genome atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Neuro Oncol 17:1525–1537. https://doi.org/10.1093/neuonc/nov117 - DOI - PubMed - PMC

LinkOut - more resources